Friday, August 7, 2026 Login
Breaking
Yusuf Pathan asks Shah to step in, halt removal of Murshidabad loudspeakers Trump confronted Hegseth over weapons shortage due to Iran war? US president reacts ‘Operation Safed Sagar’: Inside Netflix’s Kargil War Series Vivo S2 launched in India with 7000mAh battery, dual-camera & 120Hz display 2026 Mahindra Scorpio N Facelift Vs Mahindra Thar Roxx: Detailed Comparison
Health

Ebola Response Turns to Merck Vaccine, Gilead Drug as Congo Outbreak Worsens – Bloomberg.com

  1. Ebola Response Turns to Merck Vaccine, Gilead Drug as Congo Outbreak Worsens  Bloomberg.com
  2. Moderna begins first human trial of Bundibugyo Ebola vaccine  The Hindu
  3. Treatment trials for Ebola strain behind Congo outbreak show promise, WHO says  ET HealthWorld
  4. Canada Approves Clinical Trials Of Moderna’s Ebola Vaccine  NDTV
  5. Moderna stock: Ebola Phase 1 trial signals platform expansion, not near-term revenue  Investing.com

Source link

Related Stories

Leave a Comment

Your email address will not be published. Required fields are marked *